Overview

A Drug-Drug Interaction Study of ALKS 5461 in Healthy Volunteers

Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the impact of Itraconazole on the pharmacokinetics of ALKS 5461.
Phase:
Phase 1
Details
Lead Sponsor:
Alkermes, Inc.
Treatments:
Hydroxyitraconazole
Itraconazole